Publications by authors named "Asier Selas"

Claim this Profile
A
A patent review of topoisomerase 1 inhibitors (2021-present).
Maria Fuertes, Endika Martín-Encinas, Asier Selas, Concepcion Alonso

Expert Opin Ther Pat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the adenosinergic axis in cancer immunotherapy: Insights into A and A receptors and novel clinical combination strategies.
Iván Rodríguez-Pampín, Lucía González-Pico, Asier Selas, Antonio Andújar, Rubén Prieto-Díaz

Pharmacol Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.
Endika Martin-Encinas, Maria Fuertes, Carme Masdeu, Asier Selas, Concepcion Alonso

Expert Opin Investig Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB Agonists with Neuroprotective Effects.
Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz, Marialessandra Contino, Jhonny Azuaje, Asier Selas

J Med Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and discovery of topoisomerase I inhibitors as anticancer therapies.
Endika Martín-Encinas, Asier Selas, Francisco Palacios, Concepción Alonso

Expert Opin Drug Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
María Fuertes, Asier Selas, Angela Trejo, Birgitta R Knudsen, Francisco Palacios

Bioorg Med Chem Lett· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B).
Asier Selas, María Fuertes, Estela Melcón-Fernández, Yolanda Pérez-Pertejo, Rosa M Reguera

Pharmaceuticals (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and Fast DNA Based Sensor System for Screening of Small-Molecule Compounds Targeting Eukaryotic Topoisomerase 1.
Kamilla Vandsø Petersen, Asier Selas, Kirstine Mejlstrup Hymøller, Karol Mizielinski, Maria Thorsager

Pharmaceutics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patent review of topoisomerase I inhibitors (2016-present).
Asier Selas, Endika Martin-Encinas, Maria Fuertes, Carme Masdeu, Gloria Rubiales

Expert Opin Ther Pat· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines.
Maria Fuertes, Carme Masdeu, Endika Martin-Encinas, Asier Selas, Gloria Rubiales

Molecules· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused 1,5-Naphthyridines: Synthetic Tools and Applications.
Carme Masdeu, Maria Fuertes, Endika Martin-Encinas, Asier Selas, Gloria Rubiales

Molecules· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.
Endika Martín-Encinas, Asier Selas, Cinzia Tesauro, Gloria Rubiales, Birgitta R Knudsen

Eur J Med Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents.
Ana Tejería, Yolanda Pérez-Pertejo, Rosa M Reguera, Rubén Carbajo-Andrés, Rafael Balaña-Fouce, Asier Selas

Eur J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.
Concepción Alonso, María Fuertes, Endika Martín-Encinas, Asier Selas, Gloria Rubiales

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis